Drug profile · INN
diltiazem
CARDIZEM
diltiazem (CARDIZEM) is a voltage-gated l-type calcium channel blocker. Associated with Sanofi-aventis Healthcare Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — diltiazem
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
diltiazem (CARDIZEM) is a voltage-gated l-type calcium channel blocker. Associated with Sanofi-aventis Healthcare Pty Ltd.
Key facts
INN diltiazem
Brand CARDIZEM
Mechanism Voltage-gated L-type calcium channel blocker
Originator Sanofi-aventis Healthcare Pty Ltd
Mechanism of action
Voltage-gated L-type calcium channel blocker
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is diltiazem?
diltiazem (CARDIZEM) is a voltage-gated l-type calcium channel blocker. Associated with Sanofi-aventis Healthcare Pty Ltd.
What is the brand name for diltiazem?
CARDIZEM is a marketed brand name for diltiazem. Check FDA Drugs@FDA for the current US label holder and prescribing information.